Enacecor 20/12.5 mg Tablet

Enacecor 20/12.5 mg Tablet is a combination medication containing enalapril (20 mg) and hydrochlorothiazide (12.5 mg), used primarily for the treatment of essential hypertension. Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that helps relax blood vessels, while hydrochlorothiazide is a diuretic that reduces fluid retention. This combination is typically prescribed when blood pressure is not adequately controlled with enalapril alone. The product is manufactured in multiple countries and is marketed under the brand name Enacecor. The ultimate owner of the Enacecor brand is AbbVie Inc., a U.S.-based biopharmaceutical company specializing in various therapeutic areas. There is no specific information available regarding the country of origin or the original company that developed the Enacecor brand. Additionally, no subsidiary information is available for this brand.